N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells.
作者信息
Crabtree G W, Agarwal R P, Parks R E, Lewis A F, Wotring L L, Townsend L B
出版信息
Biochem Pharmacol. 1979 May 1;28(9):1491-500. doi: 10.1016/0006-2952(79)90463-5.
PMID:475858
Abstract
摘要
相似文献
1
N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells.
Biochem Pharmacol. 1979 May 1;28(9):1491-500. doi: 10.1016/0006-2952(79)90463-5.
2
2-Fluoroformycin and 2-aminoformycin. Synthesis and biological activity.2-氟甲酰霉素和2-氨基甲酰霉素。合成与生物活性。
J Med Chem. 1985 Nov;28(11):1740-2. doi: 10.1021/jm00149a033.
3
Cyclic phosphates of formycin.
J Antibiot (Tokyo). 1978 May;31(5):456-67. doi: 10.7164/antibiotics.31.456.
4
Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin.腺苷脱氨酶抑制剂2'-脱氧助间型霉素增强虫草素（3'-脱氧腺苷）的生物活性
Biochem Pharmacol. 1976 Jun 15;25(12):1441-4. doi: 10.1016/0006-2952(76)90121-0.
5
Specificity of adenosine deaminase inhibitors.
Biochem Pharmacol. 1977 Nov 1;26(21):1967-72. doi: 10.1016/0006-2952(77)90003-x.
6
Antiviral and antimetabolic activities of formycin and its N1-, N2-, 2'-O- and 3'-O-methylated derivatives.
Biochem Pharmacol. 1975 Oct 1;24(19):1813-7. doi: 10.1016/0006-2952(75)90462-1.
7
Adenosine metabolism in cultured lymphoid cells.培养的淋巴细胞中的腺苷代谢
Adv Enzyme Regul. 1976;15:169-93. doi: 10.1016/0065-2571(77)90015-2.
8
9
Formycin anhydronucleosides. Conformation of formycin and conformational specificity of adenosine deaminase.间型霉素脱水核苷。间型霉素的构象及腺苷脱氨酶的构象特异性。
J Am Chem Soc. 1975 Oct 1;97(20):5896-903. doi: 10.1021/ja00853a041.
10
Control of red blood cell adenine nucleotide metabolism studies of adenosine deaminase.
Prog Clin Biol Res. 1978;21:319-38.
引用本文的文献
1
Evaluation of a common receptor-complement concept for predicting the antileukemic activity of nucleosides.评估一种用于预测核苷抗白血病活性的共同受体-补体概念。
Proc Natl Acad Sci U S A. 1979 Aug;76(8):4075-8. doi: 10.1073/pnas.76.8.4075.
Zotero 插件